On 7 April 2022, Glenmark Pharmaceuticals repurchased an aggregate principal amount of US$75,000,000 of the US$200,000,000 2.00 per cent Resettable Onward Starting Equity-linked Securities Due 2022 (ISIN: XS1426780125; Common Code: 142678012) (Bonds) (Repurchase).
The Repurchase was carried out by way of on-market purchases via The Hongkong and Shanghai Banking Corporation. The Bonds are listed on the Singapore Exchange Securities Trading.
The settlement and cancellation for the repurchased Bonds had completed on 7 April 2022. Following cancellation, the aggregate outstanding principal amount of the Bonds will be US$750,000.
Powered by Capital Market – Live News
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
